Genetic Nutrition India Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 04-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 04-11-2024
- Company Age 2 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
About Genetic Nutrition India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Uday Shankar, Prasannakumar Sandesh, and Kailasnath Neha serve as directors at the Company.
- CIN/LLPIN
U15490KA2022PTC156509
- Company No.
156509
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jan 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Genetic Nutrition India Private Limited offer?
Genetic Nutrition India Private Limited offers a wide range of products and services, including Nutritional Supplements, Greenrich Capsule, Dy Misc, Calcium Iodate, Protein Hydrolysate, Cancer Tb Medicines, Adcumin Capsules, Flavors Aromatics, Food Enzymes, Medicines.
Who are the key members and board of directors at Genetic Nutrition India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasannakumar Sandesh  | Director | 12-Jan-2022 | Current |
| Uday Shankar | Director | 12-Jan-2022 | Current |
| Kailasnath Neha | Additional Director | 02-Mar-2023 | Current |
Financial Performance of Genetic Nutrition India.
Genetic Nutrition India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Genetic Nutrition India?
Unlock access to Genetic Nutrition India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genetic Nutrition India?
Genetic Nutrition India has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genetic Nutrition India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genetic Nutrition India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
